Senior Director, Portfolio Integration Lead
Leads scientific and strategic integration across multiple oncology development programs, ensuring alignment with disease biology, biomarker strategies, and clinical innovation. Acts as a cross-asset expert to drive portfolio coherence, clinical trial design, and engagement with external advisors. Focuses on advancing high-impact cancer therapies through data-driven decision-making and emerging technologies like AI.